East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, “Cambrex”) will be exhibiting at the 2012 American Association of Pharmaceutical Sciences (AAPS) Meeting and Exposition, October 15-18 in Chicago, IL.
Attendees are invited to visit Cambrex’s booth to learn about the Company’s wide range of custom development and manufacturing services as well as an extensive product list of over 120 generic and branded Active Pharmaceutical Ingredients (APIs) and intermediates, and drug delivery technologies, including Camouflage® taste-masking technology, which enhances the efficacy of finished drug products for the pharmaceutical industry.
Cambrex will be showcasing its global development and manufacturing capabilities including specialized offerings related to DEA controlled substances (Schedule II-IV), high potency APIs, high energy chemistries and enzymatic biotransformation technologies.
Cambrex also provides high quality and competitively priced pharmaceutical drug product, formulation, development and manufacturing capabilities designed to accelerate commercialization of finished drug products for the pharmaceutical industry with specific expertise in Nicotine Replacement Therapy (NRT).
Stop by and see us at Booth 4933 at McCormick Place, Chicago, IL.